These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 9544786)
1. New visions in the pharmacology of anticonvulsion. Löscher W Eur J Pharmacol; 1998 Jan; 342(1):1-13. PubMed ID: 9544786 [TBL] [Abstract][Full Text] [Related]
2. The new generation of GABA enhancers. Potential in the treatment of epilepsy. Czuczwar SJ; Patsalos PN CNS Drugs; 2001; 15(5):339-50. PubMed ID: 11475940 [TBL] [Abstract][Full Text] [Related]
3. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN; Sander JW Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [TBL] [Abstract][Full Text] [Related]
4. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Löscher W Seizure; 2011 Jun; 20(5):359-68. PubMed ID: 21292505 [TBL] [Abstract][Full Text] [Related]
5. [The role of gamma-aminobutyric acid in the mechanism of action of anticonvulsant drugs]. Chmielewska B Neurol Neurochir Pol; 2000; 34(1):133-43. PubMed ID: 10849911 [TBL] [Abstract][Full Text] [Related]
6. [Anticonvulsive drug therapy. Historical and current aspects]. Bauer J; Elger CE Nervenarzt; 1995 Jun; 66(6):403-11. PubMed ID: 7543658 [TBL] [Abstract][Full Text] [Related]
7. The spectrum of the new antiepileptic drugs. Perucca E Acta Neurol Belg; 1999 Dec; 99(4):231-8. PubMed ID: 10674140 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs. Stefanović S; Janković SM; Novaković M; Milosavljević M; Folić M Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):153-159. PubMed ID: 29268032 [TBL] [Abstract][Full Text] [Related]
10. New drugs for persons with epilepsy. Blum DE Adv Neurol; 1998; 76():57-87. PubMed ID: 9408464 [TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action of antiepileptic drugs and new antiepileptic drugs]. Armijo JA; Adin J; Sánchez MB Rev Neurol; 2006 Oct; 43 Suppl 1():S17-41. PubMed ID: 17061186 [TBL] [Abstract][Full Text] [Related]
12. Challenges in the clinical development of new antiepileptic drugs. Franco V; French JA; Perucca E Pharmacol Res; 2016 Jan; 103():95-104. PubMed ID: 26611249 [TBL] [Abstract][Full Text] [Related]
14. Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs. Löscher W; Leppik IE Epilepsy Res; 2002 Jun; 50(1-2):17-20. PubMed ID: 12151113 [TBL] [Abstract][Full Text] [Related]
15. Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study. Sills GJ; Butler E; Thompson GG; Brodie MJ Seizure; 1999 Oct; 8(7):404-11. PubMed ID: 10600581 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Klitgaard H; Matagne A; Gobert J; Wülfert E Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649 [TBL] [Abstract][Full Text] [Related]
18. [Antiepileptic drugs in North America]. Akiyama T; Otsubo H Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099 [TBL] [Abstract][Full Text] [Related]
19. Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice. Natsch S; Hekster YA; Keyser A; Deckers CL; Meinardi H; Renier WO Drug Saf; 1997 Oct; 17(4):228-40. PubMed ID: 9352959 [TBL] [Abstract][Full Text] [Related]
20. New antiepileptic drug development. Dreifuss FE Epilepsia; 1994; 35 Suppl 5():S6-9. PubMed ID: 7518768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]